Page last updated: 2024-11-13

deltibant

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID70697628
CHEMBL ID2103953
SCHEMBL ID1230580
MeSH IDM0193820

Synonyms (15)

Synonym
140661-97-8
deltibant
d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylgylcyl-l-phenylalanyl-l-cysteinyl-d-phenylalanyl-l-leucyl-l-arginine, 7,7'-bis(sulfide) with (2r,2's)-n,n'-hexamethylenebis(2-mercaptosuccinimide)
unii-6151j4v7vx
d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolyl-s-(1-(6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)hexyl)-2,5-dioxo-3-pyrrolidinyl)-l-cysteinyl-l-phenylalanyl-l-seryl-d-phenylalanyl-l-leucyl-l-arginine (5-5')-sulfide with d-arginyl-l-arginyl-l-prolyl-tran
l-arginine, d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolyl-s-(1-(6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)hexyl)-2,5-dioxo-3-pyrrolidinyl)-l-cysteinyl-l-phenylalanyl-l-seryl-d-phenylalanyl-l-leucyl-, (5-5')-sulfide with d-arginyl-l-arginyl-l-prolyl-t
deltibant [usan:inn]
6151j4v7vx ,
CHEMBL2103953
SCHEMBL1230580
deltibant [who-dd]
207511-94-2
deltibant [inn]
deltibant [usan]
deltibant [mi]

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Notably, drug dosage and the measure chosen to assess outcome influenced the probability of finding a treatment benefit."( Impact of early pharmacological treatment on cognitive and behavioral outcome after traumatic brain injury in adults: a meta-analysis.
Mathias, JL; Vink, R; Wheaton, P, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (66.67)18.2507
2000's5 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.49 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (20.00%)5.53%
Reviews6 (40.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]